Phase II Data In Crohn's Disease For Celgene's Oral Antisense Therapy GED-0301 To Be Presented At UEG Week 2014

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.